Tiny particles could solve billion-dollar problem
New research from Rice University's Center for Biological and Environmental Nanotechnology finds that nanoparticles of gold and palladium are the most effective catalysts yet identified for remediation of one of the nation's most pervasive and troublesome groundwater pollutants, trichloroethene or TCE. The research, conducted by engineers at Rice and the Georgia Institute of Technology, w...A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
Based on successful animal studies, a novelvaccine that uses immune cells as factories to produce Her2/neu proteinmay offer a way to treat some human breast cancers, say researchers atThe University of Texas M. D. Anderson Cancer Center. [Ed : is a protein often present / surexpressed in <a href="http://en.wikipedia.org/...UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
Experts in bioengineering, imaging, molecular genetics, immunology, ethics, hematology/oncology and cellular biology to collaborate on Proposition 71 research Drawing together experts from fields as diverse as engineering to molecular biology, UCLA officials announced March 16 the formation of the Institute for Stem Cell Biology and Medicine to conduct embryonic and adult stem cell resear...Six million Africans face famine because of locusts, drought
With locusts and drought having destroyed crops and stripped grazing land for six million people across West Africa, small farmers have started selling livestock cheaply and eating the seed corn they should plant during next month's expected rains, the United Nations Office for the Coordination of Humanitarian Affairs (OCHA) said today. "The combined effect of drought and locust attack, pa...Grow Milwaukee includes millions for tech funding
The package, which Doyle alluded to in last week's <a href="http...Gala Biotech among companies sold for $3.3 billion
for $3.3 billio...Cingular Wireless to invest $300 million in Illinois and Wisconsin
Nationwide, the company will spend $6.2 billion to enhance and expand its Allover network nationwide over the next year. Earlier year,...Platypus Technologies receives $1.6 million NIH grant
The Small Business Innovation Research grant is for continued development of the company's proprietary liquid crystal based technology to enable faster screening of drugs for treatment of cancer. The com...Massachusetts firm to buy UW spinoff Bone Care for $600 million
Bone Care and Genzyme, a 24-year-old company with annual revenues of more than $2 billion and almost 7,000 employees w...Drug May Make Breathing Easier for Millions
An experimental drug could make millions of people suffering from smoker’s lung breathe much easier. Chronic Obstructive Pulmonary Disease (COPD) or smoker’s lung, is an irreversible progressive illness caused by narrowing of the airways. It encompasses emphysema and chronic bronchitis. In tests involving 500 people who had suffered from COPD for more than a decade, the drug appeared...Multi billion-dollar suit filed against cell phone firm for causing brain tumours
In the United States of America, a lawyer- Peter Angelos, who won millions of dollars as compensation from the tobacco industry in Maryland, has announced that he is dragging Vodafone to court in a billion dollar suit. He is claiming compensation to cell phone users who are said to have developed brain tumours after using the instruments made by Verizon wireless. This case has raised eyeb...Hundred million dollar gift for malaria institute
An anonymous donor has gifted 100 million dollars to Johns Hopkins University in the United States of America to set up a malaria institute. This would be the world’s foremost center for malaria research in the world. Public health experts say the Johns Hopkins Malaria Institute will put the university at the forefront of efforts to find an effective vaccine and new treatments for the mo...George Bush pledges 200 million dollars for AIDS relief
American president George .W. Bush has pledged 200 million dollars to fight AIDS. The money will be directed toward a United Nations fund designed to pay for treatment and prevention of HIV/AIDS, as well as malaria and tuberculosis. Those three diseases together killed some 5.5 million people last year, the bulk of them in Africa,according to the World Health Organization (WHO). The shee...Healthcare sector is now a multi billion-dollar industry in India
A Confederation of Indian Industry study has identified the health care sector in India as a potential gold mine. India is poised to develop into a 'regional healthcare hub' with the $17 billion healthcare industry growing at a rate of 13 per cent the study says. With a 16% increase in budgetary outlay the healthcare industry is poised to zoom ahead bringing with it big bucks as returns....LionHeart Left Ventricular Assist System (LVAS)
Description:The Arrow LionHeart Left Ventricular Assist System (LVAS), manufactured by Arrow International, Inc., is designed to be used as a destination therapy for patients with progressive, irreversible, end-stage (Class IV) congestive heart failure, for which heart transplantation is not an option. The Arrow LionHeart LVAS is not intended as a bridge to transplant or as a bridge to recovery of ventricula...Pelosi: Bush Veto of Stem Cell Bill Says 'No' to the Hopes of Million of Families Across America
WASHINGTON, June 20, 2007 /PRNewswire-USNewswire/ -- SpeakerNancy Pelosi issued the following statement today in response toPresident Bush's veto of the stem cell bill: "Once again, the President has ignored the will of the Americanpeople, of leading medical researchers, and of a bipartisanmajority of the Congress. His cruel veto says 'no' to the hopes ofmillion of families across...Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data at ASCO
MONTRÉAL, June 1, 2007 – Thallion Pharmaceuticals Inc.(TSX: TLN) announced today that preliminary data from its PhaseI/II clinical trial investigating ECO-4601 in advanced cancerpatients was published in abstract form as part of the AmericanSociety of Clinical Oncology (ASCO) Annual Meeting in Chicago,Illinois. In the Phase I dose escalation portion of the study, 14patients (te...Achillion Presents Positive Data on Novel Mechanism for Treating HCV at EASL Annual Meeting
-NS4A Antagonist Demonstrates Clinical Activity, a Novel Mechanismof Action and In Vitro Compatibility with other HCV Inhibitors- NEW HAVEN, Conn., April 16, 2007 /PRNewswire-FirstCall/ --Achillion Pharmaceuticals, Inc. today announced the presentation ofdata validating the clinical antiviral activity of one ofAchillion's NS4A antagonists, ACH-806, for the treatment ofhepatitis C virus (H...Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
April is STD Awareness Month: Time to Pay Attention to thisOverlooked Disease SAN ANTONIO, Texas, April 02, 2007 /PRNewswire/ -- DuringNational Sexually Transmitted Disease (STD) Awareness Month thisApril, Mission Pharmacal is urging increased awareness of, andtesting for, trichomoniasis (also known as "trich"), the mostcommon curable STD in the United States. Awareness of the conditionr...Actelion Announces Positive Study with Bosentan (Tracleer) in CTEPH
First-Ever Placebo-controlled Study in Inoperable ChronicThromboembolic Pulmonary Hypertension - Primary Endpoint ofReduction in Pulmonary Vascular Resistance Met - Six-Minute-walkTest Unchanged - Significant Effect on Dyspnoea Score andBiological Disease Marker ALLSCHWIL, Switzerland, March 5, 2007 -Actelion Ltd (SWX:ATLN) announced today the initial results from the doub...